Home > Insider Trading > Filing (0001654954-19-014150)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645469	Monopar Therapeutics	MNPR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1035909	J Michael Brown	C/O Euronet Worldwide, Inc. 3500 College Blvd Leawood KS 66211		No	No	No	No
1727334	Chandler Robinson	1000 Skokie Blvd, Ste 350 Wilmette IL 60091	Chief Executive Officer	No	No	No	No
1727357	Tactic Pharma Llc	C/O 1000 Skokie Blvd, Ste 350 Wilmette IL 60091		No	No	No	No
1727393	Paul Andrew Mazar	1000 Skokie Blvd, Ste 350 Wilmette IL 60091	Chief Scientific Officer	No	No	No	No
1727481	V. Thomas O'halloran	1000 Skokie Blvd., Ste 350 Wilmette IL 60091		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-18	125,000	$8.00	291,667	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,111,273	Indirect	See Footnotes (1) and (2)

Footnotes

This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.
Tactic has voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC.